NEW YORK (GenomeWeb News) – Beckman Coulter said yesterday it has agreed to buy the remaining 80.1 percent of NexGen Diagnostics, a spin-out of Lumigen, which it bought in late 2006 for $185 million. 
 
NexGen owns intellectual property that Beckman Coulter hopes to use for immunoassay and nucleic acid-based diagnostic testing.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.